Anti-alpha Synuclein (phospho S129)抗体[EP1536Y] (ab51253)

发表研究结果有使用 ab51253?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab51253 被引用在 19 文献中.

  • Gispert S  et al. Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression. Hum Mol Genet 24:1061-76 (2015). WB, IHC-P, IHC-FrFl ; Mouse . PubMed: 25296918
  • Sasaki A  et al. Sensitive western blotting for detection of endogenous Ser129-phosphorylated a-synuclein in intracellular and extracellular spaces. Sci Rep 5:14211 (2015). WB ; Human . PubMed: 26381815
  • Song LK  et al. Targeted Overexpression of a-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse. PLoS One 10:e0131281 (2015). ICC/IF . PubMed: 26114655
  • Spinelli KJ  et al. Curcumin Treatment Improves Motor Behavior in a-Synuclein Transgenic Mice. PLoS One 10:e0128510 (2015). PubMed: 26035833
  • Neuner J  et al. A30P a-Synuclein interferes with the stable integration of adult-born neurons into the olfactory network. Sci Rep 4:3931 (2014). IHC-FrFl ; Mouse . PubMed: 24488133
  • Arawaka S  et al. Zonisamide attenuates a-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease. PLoS One 9:e89076 (2014). WB ; Rat . PubMed: 24586512
  • Pérez-Revuelta BI  et al. Metformin lowers Ser-129 phosphorylated a-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis 5:e1209 (2014). ICC/IF ; Mouse . PubMed: 24810045
  • Spinelli KJ  et al. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. J Neurosci 34:2037-50 (2014). WB, ICC/IF . PubMed: 24501346
  • Kellie JF  et al. Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry. Sci Rep 4:5797 (2014). WB ; Human . PubMed: 25052239
  • Beekes M  et al. Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles? Acta Neuropathol 128:463-76 (2014). IHC . PubMed: 25073522
  • Wang S  et al. Phosphatidylethanolamine deficiency disrupts a-synuclein homeostasis in yeast and worm models of Parkinson disease. Proc Natl Acad Sci U S A 111:E3976-85 (2014). PubMed: 25201965
  • Amschl D  et al. Time course and progression of wild type a-synuclein accumulation in a transgenic mouse model. BMC Neurosci 14:6 (2013). ICC/IF ; Human . PubMed: 23302418
  • Oliveras-Salvá M  et al. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Mol Neurodegener 8:44 (2013). WB . PubMed: 24267638
  • Chu Y  et al. Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. Brain 135:2058-73 (2012). ICC/IF ; Human . PubMed: 22719003
  • Wang S  et al. a-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2. Proc Natl Acad Sci U S A 109:16119-24 (2012). WB . PubMed: 22988096
  • Foulds PG  et al. Phosphorylated a-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease. FASEB J 25:4127-37 (2011). PubMed: 21865317
  • Mbefo MK  et al. Phosphorylation of synucleins by members of the Polo-like kinase family. J Biol Chem 285:2807-22 (2010). IHC-P ; Mouse . PubMed: 19889641
  • Liu P  et al. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression. Brain Res 1307:134-41 (2010). WB ; Human . PubMed: 19852948
  • Schell H  et al. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Neuroscience 160:796-804 (2009). ICC/IF, IHC-P ; Mouse . PubMed: 19272424